Clinical Trial

Neutralizing Interferon Type 1 in Hidradenitis Suppurativa

Study acronym: NIHS-I
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to evaluate the safety and type 1 Interferon (IFN) neutralization in patients with refractory severe Hidradenitis Suppurativa (Hurley stage III) after transfusion of plasma containing high titer anti-IFN-1 autoantibodies.
Trial Details
NCT Number NCT07067099
Lead Sponsor Centre Hospitalier Universitaire de Besancon
Collaborators: Etablissement Français du Sang
Conditions Hidradenitis Suppurativa (HS)
Enrollment 6 participants
Start Date 2025-09
Primary Completion 2026-06 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-07-16